Try our Advanced Search for more refined results

Deals Rumor Mill: Centrexion, Dayco, JD Group

By Adam Rhodes (November 15, 2018, 5:48 PM EST) -- Boston-based Centrexion Therapeutics Corp. has decided to postpone its plans to go public, according to a Thursday report from Renaissance Capital. The company has not made any announcements or filings with the U.S. Securities and Exchange Commission about the reported move. The biotechnology firm, represented by Latham & Watkins LLP, expected to raise about $75 million in the initial public offering....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!